|
Michael S. Paull joined NineSigma in December 2006 as Chief Financial Officer. Prior to joining NineSigma, Paull was CFO of Ogenix Corporation, a medical device company serving the chronic wound care market. Paull has served in finance roles at multiple manufacturing and healthcare firms ranging from start-ups through large publicly held companies, including Culligan Water Technologies and OptionCare, Inc. He worked for Fidelity Investments in private equity for six years where he was involved in a variety of transactions and global business start-ups. Paull has more than 16 years of experience in financial planning, analysis and management.
Paull earned an MBA from Loyola University Chicago and a BS in Finance from Indiana University. Paull also is a Certified Public Accountant. | 